Nouscom
  • Home
  • About
  • Technology
  • Pipeline
  • Investors
  • News
    • Grants
    • Meetings
    • Press Releases
    • Publications
  • Contact
Next-generation treatment for cancer Next-generation treatment for cancer Next-generation treatment for cancer Next-generation treatment for cancer
  • Home
  • About
  • Technology
  • Pipeline
  • Investors
  • News
    • Grants
    • Meetings
    • Press Releases
    • Publications
  • Contact

Archives

Monthly Archive for: "Maggio, 2021"
Home » Archivi per Maggio 2021
0

Dr. Marina Udier will join a live session at the 21st BioEquity Europe on Tuesday, May 18, 11:30 am CET.

The Next aCGT Europe Needs to Leapfrog — How? Follow the link below for more details. https://lnkd.in/dpAnmJZ  

READ MORE
Contact
  • NOUSCOM
  • info@nouscom.com
  • nouscom.com
Our Privacy

Privacy Policy & Cookie Low

Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

© Copyright 2018 | Made with by
error: Content is protected !!!